Nipah Virus: COVID Antiviral VV116 Shows Promise
A chilling statistic: the global mortality rate for Nipah virus can reach 40-75%, dwarfing the initial concerns surrounding COVID-19. Now, a surprising development offers a beacon of hope. Researchers at the Wuhan Institute of Virology are reporting significant antiviral activity of an oral nucleoside drug, originally developed to combat COVID-19, against the deadly Nipah virus. … Read more